Connecting you to content on EBSCOhost

Works matching IS 26738449 AND DT 2022 AND VI 2 AND IP 3

Results: 4

1

Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours.

Published in:

Biologics, 2022, v. 2, n. 3, p. 196, doi. 10.3390/biologics2030015

By:

Stone, Jaqueline C.;
Ndarukwa, Pisirai;
Scheim, David E.;
Dancis, Barry M.;
Dancis, Jerome;
Gill, Martin G.;
Aldous, Colleen

Publication type:

Article

2

Why Are We Still Talking about Ivermectin? Editorial Note on Stone et al. Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment.

Published in:

2022

By:

Pincus, Seth H.

Publication type:

Editorial

3

Biosimilars: Harmonizing the Approval Guidelines.

Published in:

Biologics, 2022, v. 2, n. 3, p. 171, doi. 10.3390/biologics2030014

By:

Niazi, Sarfaraz K.

Publication type:

Article

4

Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes.

Published in:

2022

By:

Chavda, Vivek P.;
Chhabria, Mahesh T.;
Apostolopoulos, Vasso

Publication type:

Editorial